Please assess the completion status of the following clinical trial:

Trial Title: Daytime Impact Sleep Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* At least 2 night time voids per night~* Habitual sleep of 6-9.5 hours per night~* Experiencing symptoms of Nocturia greater than 6 months~Exclusion Criteria:~* Greater than 10 night time voids~* History of sleep apnoea and PLMS (Periodic Limb Movements of Sleep)~* Other sleep disorders~* Signs or symptoms of: Bladder outlet obstruction, severe lower urinary tract symptoms (LUTS), interstitial cystitis, moderate to severe overactive bladder (OAB), moderate to severe as judged by the investigator stress urinary incontinence~* Urological malignancies~* Neurogenic detrusor over activity (e.g. Parkinson, spinal cord damage, etc.)~* Central or nephrogenic diabetes insipidus~* Habitual or psychogenic polydipsia (fluid intake resulting in a urine production exceeding 40ml/Kg/24hrs)~* Syndrome of inappropriate antidiuretic hormone (SIADH)~* Cardiac failure evidence based on physical examination, cardiac medical history and electrocardiogram (ECG) output~* Uncontrolled hypertension~* Uncontrolled diabetes mellitus~* Hyponatraemia with sodium \<135 mmol/L~* Renal insufficiency~* Known or suspected clinically significant hepatic and/or biliary diseases

- Gender: ALL
- Minimum Age: 25 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Experimental A (Type: EXPERIMENTAL): None
- Experimental B (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).